CVS Health Corp banner

CVS Health Corp
XMUN:CVS

Watchlist Manager
CVS Health Corp Logo
CVS Health Corp
XMUN:CVS
Watchlist
Price: 61.89 EUR -1.09%
Market Cap: €78.7B

EV/EBIT

13.3
Current
38%
More Expensive
vs 3-y median of 9.6

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
13.3
=
Enterprise Value
€143.8B
/
EBIT
$10.5B

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
13.3
=
Enterprise Value
€143.8B
/
EBIT
$10.5B

Valuation Scenarios

CVS Health Corp is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (9.6), the stock would be worth €44.89 (27% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-27%
Maximum Upside
+48%
Average Upside
10%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 13.3 €61.89
0%
3-Year Average 9.6 €44.89
-27%
5-Year Average 10 €46.63
-25%
Industry Average 19.2 €89.9
+45%
Country Average 19.6 €91.64
+48%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
€143.8B
/
Jan 2026
$10.5B
=
13.3
Current
€143.8B
/
Dec 2026
$15.4B
=
9.3
Forward
€143.8B
/
Dec 2027
$17.2B
=
8.4
Forward
€143.8B
/
Dec 2028
$19.1B
=
7.5
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close

Market Distribution

Lower than 78% of companies in the United States of America
Percentile
22st
Based on 8 638 companies
22st percentile
11.5
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

CVS Health Corp
Glance View

CVS Health Corporation stands as a pivotal player in the healthcare landscape, tracing its roots back to the early 1960s as a modest chain of health and beauty stores. Evolving through strategic acquisitions and visionary leadership, it burgeoned into one of America’s foremost health solutions providers. The company operates through several segments, each contributing to a comprehensive healthcare ecosystem. Retail/LTC, its retail division, oversees a vast network of pharmacies nationwide, capitalizing on its trusted brand to serve millions of customers with prescriptions, over-the-counter medications, and everyday essentials. Through this extensive reach, CVS leverages its convenience and accessibility, capturing a significant share of consumer healthcare spending. However, CVS's business model doesn't stop at retail. It delves deeper into healthcare through its pharmacy benefits manager, Caremark, which provides employers and insurers with effective cost control for prescription drugs. Additionally, the landmark acquisition of Aetna, a leading health insurer, marked a strategic pivot towards vertically integrated healthcare services. This acquisition has enabled CVS not only to offer insurance products but also to streamline care with initiatives like MinuteClinics and HealthHUBs, aiming to reduce overall healthcare costs while improving patient outcomes. By intertwining its various services, CVS Health positions itself as a pioneer in the industry, standing at the intersection of healthcare delivery, pharmacy services, and insurance management, ultimately crafting synergies that aim to redefine the future of consumer health engagement.

CVS Intrinsic Value
119.3 EUR
Undervaluation 48%
Intrinsic Value
Price
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett